ABSTRACT
Objective: to observe the effect of abdominal obesity on fasting blood glucose levels in T2DM patients who are on treatment with oral hypoglycemic agents
Material and Methods: the study included 55 T2DM patients, who were taking oral hypoglycemic drugs for the last 3 to 5 years. Abdominal obesity was assessed by measuring waist circumference. Fasting blood glucose levels were measured in all patients
ResuIts: according to our observation there were 41.81% non-obese, 23.63% overweight and 34.54% obese T2DM patients. The obese T2DM patients had significantly higher mean fasting blood glucose level as compared to nun-obese and overweight T2DM patients [p<0.001]. Overweight T2DM patients though had higher mean fasting plasma glucose levels as compared to non-obese T2DM patients but it was not significant
Conclusion: Abdominal obesity is associated with significantly higher fasting blood glucose levels in T2DM patients who are on treatment with oral hypoglycemic agents
ABSTRACT
The present study was carried out to determine the lipoprotein patterns as an atherogenic factor in T2DM [Type 2 Diabetes Mellitus] patients and their FDRS [First Degree Relatives]. In various previous studies it has been reported that hyperinsulinemia and hyperlipidemia frequently coexist in T2DM patients which indicate that the diabetic state it self is associated with atherogenic lipid disorders. The present study included 26 Type 2DM [T2DM] patients and 21 apparently healthy First Degree Relative [FDRs] of T2DM patients. Twenty three age matched control not related to diabetics were also included in the study. The BMI in male patients and FDRs were significantly higher as compared to controls but no significant difference was seen among the BMI of female FDRs. Fasting plasma glucose [FPG] levels of T2DM patients were significantly higher but no significant difference was observed among the FDRs and controls. FPG did not show any significant correlation with the BMI in diabetic patients, FDRs and controls. The lipid profile of patients showed no significant difference, except the mean LDL-Chol of female patients was significantly higher as compared to female controls. HDL-Chol of males FDRs was significantly lower as compared to male controls. LDL-Chol of female FDRs was significantly lower than the female controls. No significant difference was observed in the total cholesterol and the triglycerides level of the patients of T2DM and FDRs but those cases in which pre-beta band appear upon lipoprotein electrophoresis had significantly higher triglyceride levels as compared to those patients in which pre-beta band did not appear. Lipoproteins of the T2DM patients and FDRs group were found to be highly disturbed as compared to the control group and they show a trend of developing atherogenic states in future